Cytopharm Inc., Glaxo Wellcome, MacroChem deal

Glaxo sublicensed MCHM’s soft enhanced percutaneous absorption (SEPA)

Read the full 81 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE